Clinical Laboratories of GensKey
GensKey operates five wholly-owned clinical laboratories in Beijing, Shanghai, Guangzhou, and Tianjin, with a total of more than 20 joint-operated emergency admissions laboratories across the country. Across major regions and cities in China, the company is capable of delivering reports within 24 hours, providing patients with reliable, accurate and rapid pathogen detection products and services.
Beijing GensKey Clinical Laboratory
Beijing GensKey Clinical Laboratory is located in the Third Block Industrial Park, Fengtai District, Beijing, with an area of 928m². It is a professional pathogenic microorganisms and genetic detection laboratory.
l In 2022, it passed the acceptance of gene amplification laboratory and the record of biosafety class II laboratory.
Beijing Shengquan Clinical Laboratory
Beijing Shengquan Clinical Laboratory is located in the Bioscience Park of Changping District, Beijing, covering an area of 515m². It is a specialized laboratory for pathogen microbiology and genetic detection.
l In 2020, it passed the acceptance of gene amplification laboratory and the record of biosafety class II laboratory.
l In 2020 and 2022, it was awarded National Inter-laboratory Quality Assessment Certificates for Metagenomic Sequencing of Lower Respiratory Tract Infections.
l In 2022 and 2023, it passed the inter-laboratory quality assessment (virology, non-virology, EB virus, cytomegalovirus and COVID-19) of the National Clinical Testing Center and obtained the certificate.
l In 2023, it attained the National Certificate for High-throughput Metagenomic cfDNA Sequencing in Blood Microbiology.
Tianjin GensKey Clinical Laboratory
Tianjin GensKey Clinical Laboratory is located in the Entrepreneurial Headquarters Base of Wuqing District, Tianjin Municipality, covering an area of 1180m². It is a specialized laboratory for pathogenic microorganism detection, utilizing high-throughput sequencing technology and PCR technology as its main diagnostic methods to provide comprehensive solutions for infectious disease patients.
l In 2019, it passed the acceptance of gene amplification laboratory and the record of biosafety class II laboratory.
In 2020 and 2022, it was awarded National Inter-laboratory Quality Assessment Certificates for Metagenomic Sequencing of Lower Respiratory Tract Infections.
l In 2021, 2022 and 2023, it passed the inter-laboratory quality assessment (virology, non-virology, EB virus, cytomegalovirus and COVID-19) of the National Clinical Testing Center and obtained the certificate.
l In 2023, it attained the National Certificate for High-throughput Metagenomic cfDNA Sequencing in Blood Microbiology.
l In 2021, 2022 and 2023, it separately acquired ISO9001、ISO13485、ISO 15189 and ISO27001 certifications.
Shanghai GensKey Clinical Laboratory
Shanghai GensKey Clinical Laboratory is situated in the Nanshang Precision Medicine Industrial Park, Jiading District, Shanghai, covering an area of 504㎡. It provides delivery experience for patients and physicians in East China to help infected patients get access to precise diagnostic and therapeutic testing services.
l In 2020, it passed the acceptance of gene amplification laboratory and the record of biosafety class II laboratory.
l In 2021, 2022 and 2023, it passed the inter-laboratory quality assessment (virology, non-virology, EB virus, cytomegalovirus and COVID-19) of the National Clinical Testing Center and obtained the certificate.
l In 2023, it achieved the Shanghai Inter-laboratory Quality Assessment Certificate for High-throughput Sequencing of Metagenomics (DNA) and Cell-free DNA Metagenomics in Plasma Microbiology in Lower Respiratory Tract Infections.
Guangzhou GensKey Clinical Laboratory
Guangzhou GensKey Clinical Laboratory is located in the Science and Technology Enterprise Accelerator Park in Huangpu District, Guangzhou City, occupying an area of 612㎡.
l In 2021, it passed the acceptance of gene amplification laboratory and the record of biosafety class II laboratory.
l In 2022 and 2023, it passed the inter-laboratory quality assessment (virology, non-virology, EB virus, cytomegalovirus and COVID-19) of the National Clinical Testing Center and obtained the certificate.